Safety, Tolerability and Pharmacokinetics of FTP-198 in Healthy Australian Volunteers
Clinical trial NCT04526496 · COMPLETED
Trial details
- NCT number
- NCT04526496
- Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-24
- Primary completion
- 2020-11-05
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.